UNSPSC 51144501: Pramiracetam hydrochloride

This classification denotes a neuroprotective agent with the molecular formula C14H27N3O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WIU553VC0S, chemically known as 1-pyrrolidineacetamide, n-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-, monohydrochloride; but more generally known as pramiracetam hydrochloride, which bears US NIH Compound Identifier 3050410. European Medicines Agency schedules Pramiracetam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04005MIG.

UNSPSC 51144501 Pramiracetam hydrochloride is a Commodity code with minimal recent state and local procurement activity directly aligned to its nominal scope. The code shows no recent solicitations for pramiracetam hydrochloride specifically. The three most recent opportunities tagged to this code involve naloxone procurement, a direct-to-manufacturer pharmacy program inquiry, and multi-source generic pharmaceuticals and over-the-counter products — none of which represent pramiracetam hydrochloride or its therapeutic class. This mismatch suggests either a cataloging error in the tagging system or a code used as a catch-all placeholder for pharmaceutical commodities more broadly.

Of the tagged opportunities, Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: the deadline date appears inconsistent with the posting date). The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment capabilities as a preliminary market intelligence effort. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 on January 20, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026. The limited and divergent activity under this code suggests it does not represent active or coherent state and local procurement for pramiracetam hydrochloride; business development professionals should verify the correct commodity code before pursuing opportunities.